Showing results (1411-1420 of 1,479) with videos related to
Sort By:
Pageof 148
EMBO Molecular Medicine|January 6, 2010
Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDECOscar Rubio-Cabezas, Vishwajeet Puri, Incoronata Murano, et al.Proceedings of the National Academy of Sciences of the United States of America|February 12, 2013
Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigenEnrico Malito, Agnese Faleri, Paola Lo Surdo, et al.Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.The Lancet. Oncology|October 1, 2016
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup studyJaap C Reijneveld, Martin J B Taphoorn, Corneel Coens, et al.JAMA|March 7, 2023
Effect of Intrapartum Azithromycin vs Placebo on Neonatal Sepsis and Death: A Randomized Clinical TrialAnna Roca, Bully Camara, Joel D Bognini, et al.Kidney International Reports|May 22, 2026
Clinical Equipoise and Unimproved Outcomes following Posttransplant Cutaneous Squamous Cell CarcinomaTom H J Crisp, Emilia Peleva, Rachel Abbott, et al.Standards in Genomic Sciences|July 30, 2016
Complete genome of Nitrosospira briensis C-128, an ammonia-oxidizing bacterium from agricultural soilMarlen C Rice, Jeanette M Norton, Frederica Valois, et al.Lancet (London, England)|August 21, 2022
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trialDavid J Beard, Loretta Davies, Jonathan A Cook, et al.Health Technology Assessment (Winchester, England)|June 28, 2024
Comparison of surgical or non-surgical management for non-acute anterior cruciate ligament injury: the ACL SNNAP RCTDavid J Beard, Loretta Davies, Jonathan A Cook, et al.The Lancet. Oncology|June 3, 2023
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and proceduresMadeline Pe, Ahu Alanya, Ragnhild Sorum Falk, et al.Pageof 148